Black patients with generalized MG may face health inequities: Study

European panel recommends nipocalimab approval for gMG

A European Medicines Agency (EMA) committee recommended that the agency approve nipocalimab as an add-on treatment for generalized myasthenia gravis (gMG) patients aged 12 and older who have antibodies against acetylcholine receptor (AChR) or muscle-specific kinase (MuSK). The Committee for Medicinal Products for Human Use (CHMP) recommendation comes a…

My brother takes precautions to safely navigate his home

As I enter my 50s, I find myself living alone as an expatriate in Asia, and I constantly worry about accidentally injuring myself. I’m particularly concerned about slipping and falling. I’ve realized that as we age, it’s essential to prioritize safety. Recently, I had a conversation with my twin brother,…

A Farmer’s Journey with Generalized Myasthenia Gravis

For Albert, life has always been a balancing act. Managing his family farm and a portfolio of real estate investments—often with his five grandchildren by his side—not only requires the right strategy but also a deep understanding of the value of hard work and family. Whether managing a herd of…

Why the act of breathing is a profound gift

Six years ago, before my myasthenia gravis (MG) diagnosis, I decided that I wanted to be more focused and intentional. To assist with this, I bought an app for my Apple Watch that reminds me every two hours to pause and spend a minute focusing on my breath. During…